Literature DB >> 11598018

Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing.

S Kadener1, P Cramer, G Nogués, D Cazalla, M de la Mata, J P Fededa, S E Werbajh, A Srebrow, A R Kornblihtt.   

Abstract

Here we investigate the promoter control of alternative splicing by studying two transcriptional activators on templates under replicating conditions. SV40 large T-antigen (T-Ag) activates template replication only 2-fold but transcription 25-fold. T-Ag-mediated replication, reported to inhibit RNA polymerase II elongation, provokes a 10- to 30-fold increase in the inclusion of the fibronectin EDI exon into mature mRNA. The T-Ag effect is exon specific, occurs in cis and depends strictly on DNA replication and not on cell transformation. VP16, an activator of transcriptional initiation and elongation, has a similar effect on transcription but the opposite effect on splicing: EDI inclusion is inhibited by 35-fold. VP16 completely reverts the T-Ag effect, but a VP16 mutant with reduced elongation ability provokes only partial reversion. Both T-Ag and VP16 promote conspicuous co-localization of mRNA with nuclear speckles that contain the SR protein SF2/ASF, a positive regulator of EDI inclusion. Therefore, we conclude that co-localization of transcripts and speckles is not sufficient to stimulate EDI inclusion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598018      PMCID: PMC125675          DOI: 10.1093/emboj/20.20.5759

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

Review 1.  Chromatin modification by DNA tracking.

Authors:  A Travers
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  High mobility of proteins in the mammalian cell nucleus.

Authors:  R D Phair; T Misteli
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 3.  RNA polymerase II and the integration of nuclear events.

Authors:  Y Hirose; J L Manley
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

Review 4.  Connecting transcription to messenger RNA processing.

Authors:  N Proudfoot
Journal:  Trends Biochem Sci       Date:  2000-06       Impact factor: 13.807

5.  Distribution of acetylated histones resulting from Gal4-VP16 recruitment of SAGA and NuA4 complexes.

Authors:  M Vignali; D J Steger; K E Neely; J L Workman
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 6.  Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology.

Authors:  D L Black
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

Review 7.  Structure and function of simian virus 40 large tumor antigen.

Authors:  E Fanning; R Knippers
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

8.  Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity.

Authors:  D Schmucker; J C Clemens; H Shu; C A Worby; J Xiao; M Muda; J E Dixon; S L Zipursky
Journal:  Cell       Date:  2000-06-09       Impact factor: 41.582

9.  Replication but not transcription of simian virus 40 DNA is dependent on nuclear domain 10.

Authors:  Q Tang; P Bell; P Tegtmeyer; G G Maul
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 10.  Cell biology of transcription and pre-mRNA splicing: nuclear architecture meets nuclear function.

Authors:  T Misteli
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

View more
  48 in total

1.  The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template.

Authors:  Jianming Qiu; David J Pintel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Perturbation of transcription elongation influences the fidelity of internal exon inclusion in Saccharomyces cerevisiae.

Authors:  Kenneth James Howe; Caroline M Kane; Manuel Ares
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

3.  Cotranscriptional recruitment of the U1 snRNP to intron-containing genes in yeast.

Authors:  Kimberly M Kotovic; Daniel Lockshon; Lamia Boric; Karla M Neugebauer
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

Review 4.  Multiple links between transcription and splicing.

Authors:  Alberto R Kornblihtt; Manuel de la Mata; Juan Pablo Fededa; Manuel J Munoz; Guadalupe Nogues
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

5.  Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavage.

Authors:  Emanuel Rosonina; Benjamin J Blencowe
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

6.  Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in Drosophila.

Authors:  Yevgenia L Khodor; Joseph Rodriguez; Katharine C Abruzzi; Chih-Hang Anthony Tang; Michael T Marr; Michael Rosbash
Journal:  Genes Dev       Date:  2011-12-01       Impact factor: 11.361

7.  TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Authors:  Marta Montes; Alexandre Cloutier; Noemí Sánchez-Hernández; Laetitia Michelle; Bruno Lemieux; Marco Blanchette; Cristina Hernández-Munain; Benoit Chabot; Carlos Suñé
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

8.  Vezf1 protein binding sites genome-wide are associated with pausing of elongating RNA polymerase II.

Authors:  Humaira Gowher; Kevin Brick; R Daniel Camerini-Otero; Gary Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

9.  CTCF: from insulators to alternative splicing regulation.

Authors:  Alberto R Kornblihtt
Journal:  Cell Res       Date:  2012-02-07       Impact factor: 25.617

10.  First come, first served revisited: factors affecting the same alternative splicing event have different effects on the relative rates of intron removal.

Authors:  Manuel de la Mata; Celina Lafaille; Alberto R Kornblihtt
Journal:  RNA       Date:  2010-03-31       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.